D2E Stock Overview
Adastra Holdings Ltd. operates as a cannabis extraction and processing solutions company in Canada.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Adastra Holdings Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.11 |
52 Week High | CA$0.35 |
52 Week Low | CA$0.045 |
Beta | -0.35 |
1 Month Change | -10.83% |
3 Month Change | 9.18% |
1 Year Change | -50.46% |
3 Year Change | -83.54% |
5 Year Change | n/a |
Change since IPO | -93.08% |
Recent News & Updates
Recent updates
Shareholder Returns
D2E | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 0% | 1.9% | 1.2% |
1Y | -50.5% | -28.2% | 2.0% |
Return vs Industry: D2E underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: D2E underperformed the German Market which returned 2% over the past year.
Price Volatility
D2E volatility | |
---|---|
D2E Average Weekly Movement | 97.1% |
Pharmaceuticals Industry Average Movement | 6.6% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: D2E's share price has been volatile over the past 3 months.
Volatility Over Time: D2E's weekly volatility has increased from 75% to 97% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Lachlan McLeod | adastraholdings.ca |
Adastra Holdings Ltd. operates as a cannabis extraction and processing solutions company in Canada. The company offers cannabis analytical testing, and cannabis processing services. It provides processing solutions to licensed cultivators of cannabis and hemp; and supplies cannabis extracts, such as tinctures, oils, capsules, soft gels, and sprays to qualified Canadian and international business-to-business partners.
Adastra Holdings Ltd. Fundamentals Summary
D2E fundamental statistics | |
---|---|
Market cap | €8.21m |
Earnings (TTM) | -€2.42m |
Revenue (TTM) | €15.17m |
0.5x
P/S Ratio-3.3x
P/E RatioIs D2E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
D2E income statement (TTM) | |
---|---|
Revenue | CA$22.22m |
Cost of Revenue | CA$14.66m |
Gross Profit | CA$7.57m |
Other Expenses | CA$11.11m |
Earnings | -CA$3.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.063 |
Gross Margin | 34.05% |
Net Profit Margin | -15.95% |
Debt/Equity Ratio | 24.1% |
How did D2E perform over the long term?
See historical performance and comparison